These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

409 related items for PubMed ID: 11519239

  • 1. Prevalence, costs, and treatment of Alzheimer's disease and related dementia: a managed care perspective.
    Rice DP, Fillit HM, Max W, Knopman DS, Lloyd JR, Duttagupta S.
    Am J Manag Care; 2001 Aug; 7(8):809-18. PubMed ID: 11519239
    [Abstract] [Full Text] [Related]

  • 2. Impact of donepezil use in routine clinical practice on health care costs in patients with Alzheimer's disease and related dementias enrolled in a large medicare managed care plan: a case-control study.
    Lu S, Hill J, Fillit H.
    Am J Geriatr Pharmacother; 2005 Jun; 3(2):92-102. PubMed ID: 16129386
    [Abstract] [Full Text] [Related]

  • 3. The cost of Alzheimer's disease in managed care: a cross-sectional study.
    Leon J, Neumann PJ.
    Am J Manag Care; 1999 Jul; 5(7):867-77. PubMed ID: 10557408
    [Abstract] [Full Text] [Related]

  • 4. Recommendations for best practices in the treatment of Alzheimer's disease in managed care.
    Fillit HM, Doody RS, Binaso K, Crooks GM, Ferris SH, Farlow MR, Leifer B, Mills C, Minkoff N, Orland B, Reichman WE, Salloway S.
    Am J Geriatr Pharmacother; 2006 Jul; 4 Suppl A():S9-S24; quiz S25-S28. PubMed ID: 17157793
    [Abstract] [Full Text] [Related]

  • 5. The effect of donepezil therapy on health costs in a Medicare managed care plan.
    Hill JW, Futterman R, Mastey V, Fillit H.
    Manag Care Interface; 2002 Mar; 15(3):63-70. PubMed ID: 11925682
    [Abstract] [Full Text] [Related]

  • 6. Practice guidelines for the diagnosis and treatment of Alzheimer's disease in a managed care setting: Part II--Pharmacologic therapy. Alzheimer's Disease (AD) Managed Care Advisory Council.
    Fillit H, Cummings J.
    Manag Care Interface; 2000 Jan; 13(1):51-6. PubMed ID: 10747691
    [Abstract] [Full Text] [Related]

  • 7. Managed care decisions in Alzheimer's disease.
    Fillit HM.
    Am J Manag Care; 2000 Dec; 6(22 Suppl):S1149-55; discussion S1156-60. PubMed ID: 11142179
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Health service utilization among Alzheimer's disease patients: evidence from managed care.
    Frytak JR, Henk HJ, Zhao Y, Bowman L, Flynn JA, Nelson M.
    Alzheimers Dement; 2008 Sep; 4(5):361-7. PubMed ID: 18790463
    [Abstract] [Full Text] [Related]

  • 10. 2009 Alzheimer's disease facts and figures.
    Alzheimer's Association.
    Alzheimers Dement; 2009 May; 5(3):234-70. PubMed ID: 19426951
    [Abstract] [Full Text] [Related]

  • 11. Health care utilization and costs of Alzheimer's disease: the role of co-morbid conditions, disease stage, and pharmacotherapy.
    Fillit H, Hill JW, Futterman R.
    Fam Med; 2002 May; 34(7):528-35. PubMed ID: 12144008
    [Abstract] [Full Text] [Related]

  • 12. Cognitive, global, and functional benefits of donepezil in Alzheimer's disease and vascular dementia: results from large-scale clinical trials.
    Passmore AP, Bayer AJ, Steinhagen-Thiessen E.
    J Neurol Sci; 2005 Mar 15; 229-230():141-6. PubMed ID: 15760632
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Alzheimer's disease and managed care: a convincing case for action.
    Gorshow S.
    Manag Care Interface; 2007 Mar 15; 20(3):26-7. PubMed ID: 17458478
    [Abstract] [Full Text] [Related]

  • 15. Social-economic costs and quality of life of Alzheimer disease in the Canary Islands, Spain.
    Lopez-Bastida J, Serrano-Aguilar P, Perestelo-Perez L, Oliva-Moreno J.
    Neurology; 2006 Dec 26; 67(12):2186-91. PubMed ID: 17190942
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
    Tariot PN, Cummings JL, Katz IR, Mintzer J, Perdomo CA, Schwam EM, Whalen E.
    J Am Geriatr Soc; 2001 Dec 26; 49(12):1590-9. PubMed ID: 11843990
    [Abstract] [Full Text] [Related]

  • 19. Donepezil for the treatment of mild to moderate Alzheimer's disease in France: the economic implications.
    Fagnani F, Lafuma A, Pechevis M, Rigaud AS, Traykov L, Seux ML, Forette F.
    Dement Geriatr Cogn Disord; 2004 Dec 26; 17(1-2):5-13. PubMed ID: 14560059
    [Abstract] [Full Text] [Related]

  • 20. 2008 Alzheimer's disease facts and figures.
    Alzheimer's Association.
    Alzheimers Dement; 2008 Mar 26; 4(2):110-33. PubMed ID: 18631956
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.